"Designing Growth Strategies is in our DNA"

Spinal Muscular Atrophy (SMA) Treatment Market Size, Share & Industry Analysis, By Product (Nusinersen and Onasemnogen Abeparvovec), By Disease Type (Type 1 SMA, Type 2 SMA and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Others), and Regional Forecast, 2019-2032

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI100576

 


To get information on various segments, share your queries with us

 ATTRIBUTE

 DETAILS

Study Period

  2017-2026

Base Year

  2018

Forecast Period

  2019-2026

Historical Period

  2017

Unit

  Value (USD million)

Segmentation

By Product

  • Nusinersen
  • Onasemnogen Abeparvovec

By Disease Type

  • Type 1 SMA
  • Type 2 SMA
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Others 

By Geography

  • North America (U.S. and Canada)
  • Europe (U.K., Germany, France, Italy, Spain, and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, and Rest of Asia Pacific)
  • Rest of the World
  • REPORT UPDATE
    IN PROCESS
  • 2019-2032
    (In Process)
  • 2023
    (In Process)
Multi-report Purchase Plan
    A Customized Plan Will be Created Based on the number of reports you wish to purchase